PCMH
PRAX icon

Polymer Capital Management (HK)’s Praxis Precision Medicines PRAX Stock Holding History

Polymer Capital Management (HK)’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,726
Closed -$227K – 224
2024
Q1 		$227K Buy
+3,726
New +$167K 0.06% 150

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Polymer Capital Management (HK)'s PRAX Position: Q2 2024 in Review

Polymer Capital Management (HK) sold out of Praxis Precision Medicines (PRAX) in Q2 2024, closing a stake of 3,726 shares — an estimated $227K sold.

Polymer Capital Management (HK) first reported a position in PRAX in Q1 2024 and held it in 1 quarter. The position peaked at $227K in Q1 2024. 113 funds tracked by Wall St. Rank hold PRAX as of Q2 2024.

  • Polymer Capital Management (HK) reported no remaining Praxis Precision Medicines position as of Q2 2024 after selling out during the quarter.
  • Polymer Capital Management (HK) sold 3,726 Praxis Precision Medicines shares in Q2 2024, an estimated $227K.
  • Polymer Capital Management (HK) first reported a position in Praxis Precision Medicines in Q1 2024 and held it in 1 quarter.
  • Polymer Capital Management (HK)'s Praxis Precision Medicines position peaked at $227K in Q1 2024.
  • 113 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2024.

Based on Polymer Capital Management (HK)'s 13F filing for Q2 2024, filed 14 Aug 2024.